APA (7th ed.) Citation

Jiang, J., Xu, L., Chai, L., Guan, X., Zhang, L., Liu, H., . . . Jia, Y. Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies. Wiley.

Chicago Style (17th ed.) Citation

Jiang, Juanjuan, et al. Clinical Pharmacokinetics and Pharmacodynamics of Ongericimab: A Potential Long‐acting PCSK9 Monoclonal Antibody in Healthy Subjects and Patients with Hypercholesterolemia: Randomized, Double‐blind, Placebo‐controlled Phase Ia and Ib/II Studies. Wiley.

MLA (9th ed.) Citation

Jiang, Juanjuan, et al. Clinical Pharmacokinetics and Pharmacodynamics of Ongericimab: A Potential Long‐acting PCSK9 Monoclonal Antibody in Healthy Subjects and Patients with Hypercholesterolemia: Randomized, Double‐blind, Placebo‐controlled Phase Ia and Ib/II Studies. Wiley.